Monday, February 10, 2020 2:27:04 PM
Here's some fact.
1. Eutectix role is purely ingot manufacturer (FOR NOW)
2. Eutectix has signed a similar deal with Materion (as an ingot mfr)
3. Materion itself is an ingot mfr (Beryllium heavy)
4. Materion license their so called IP is from Cal Tech root.
5. LQMT license their so called IP is from same Cal Tech root.
1. Eutectix deal also include FREE storage for LQMT current "LEFTOVER" inventory and equipment. Those inventory (especially LM105) is not known to have any present and/or future outlet. Don't forget LQMT already provided last time buy to existing "midget" customer base.
2. Eutectix does not have or plan to have any resource to do whale size mfr (just for ingot) never mind end product mfr.
3. Whale size ingot requirement will likely come from China (until Foxconn decide to hop in). Furnace in/out type of operation is mostly robotic based.
SO, WHY A DEAL EXIST?
LQMT has something that neither Materion and/or Eutectix have and becomes a MUST NEED for future growth.
BRAND BRAND BRAND
WHALE demand the BRAND
Latest lawsuit success PROTECT THE BRAND.
It is not by accident that deal is struck right after the lawsuit.
It is not by accident that lawsuit was initiated by LQMT. Please don't tell me it is for Kang sake.
BTW......all the China BMG competitors (ECO system partners) have removed all names remotely closed to LiquidMetal.
Bottom line:
ECO system has begun. Partner (competitor) has begun to "tip toe" in.
EVERYONE however has to pay BRAND license royalty.
6% of a 10 billions dollar market is not such a bad thing.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM